Mark Pimentel
#153,005
Most Influential Person Now
Researcher
Mark Pimentel's AcademicInfluence.com Rankings
Mark Pimentelengineering Degrees
Engineering
#6255
World Rank
#7571
Historical Rank
Electrical Engineering
#1835
World Rank
#1937
Historical Rank
Mark Pimentelcomputer-science Degrees
Computer Science
#8195
World Rank
#8617
Historical Rank
Computational Linguistics
#1782
World Rank
#1800
Historical Rank
Machine Learning
#3286
World Rank
#3325
Historical Rank
Artificial Intelligence
#3589
World Rank
#3640
Historical Rank
Download Badge
Engineering Computer Science
Mark Pimentel's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Mark Pimentel Influential?
(Suggest an Edit or Addition)Mark Pimentel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Rifaximin therapy for patients with irritable bowel syndrome without constipation. (2011) (859)
- Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome (2000) (753)
- Normalization of Lactulose Breath Testing Correlates With Symptom Improvement in Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Study (2003) (663)
- Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus (2017) (464)
- Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. (2006) (408)
- The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome (2006) (382)
- A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth (2008) (257)
- Methane Production During Lactulose Breath Test Is Associated with Gastrointestinal Disease Presentation (2004) (231)
- ACG Clinical Guideline: Management of Irritable Bowel Syndrome. (2020) (210)
- Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. (2016) (199)
- Methanogens, Methane and Gastrointestinal Motility (2013) (186)
- Methane and the Gastrointestinal Tract (2010) (183)
- The Degree of Breath Methane Production in IBS Correlates With the Severity of Constipation (2007) (181)
- Lower Frequency of MMC Is Found in IBS Subjects with Abnormal Lactulose Breath Test, Suggesting Bacterial Overgrowth (2002) (164)
- ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. (2020) (157)
- The Prevalence of Overgrowth by Aerobic Bacteria in the Small Intestine by Small Bowel Culture: Relationship with Irritable Bowel Syndrome (2012) (155)
- Measurement of Gastrointestinal Transit (2005) (155)
- Neomycin Improves Constipation-Predominant Irritable Bowel Syndrome in a Fashion That Is Dependent on the Presence of Methane Gas: Subanalysis of a Double-Blind Randomized Controlled Study (2006) (154)
- Abnormal Breath Testing in IBS: A Meta-Analysis (2010) (150)
- Identification of a prodromal period in Crohn's disease but not ulcerative colitis (2000) (144)
- Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance (2013) (142)
- A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing (2004) (133)
- Methanobrevibacter smithii Is the Predominant Methanogen in Patients with Constipation-Predominant IBS and Methane on Breath (2012) (130)
- Rifaximin versus Other Antibiotics in the Primary Treatment and Retreatment of Bacterial Overgrowth in IBS (2007) (126)
- Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human Subjects (2015) (121)
- Methane on Breath Testing Is Associated with Constipation: A Systematic Review and Meta-analysis (2011) (121)
- How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach (2016) (107)
- Intestinal methane production in obese individuals is associated with a higher body mass index. (2012) (97)
- Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome (2014) (95)
- Studying the Overlap Between IBS and GERD: A Systematic Review of the Literature (2006) (93)
- Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat. (2013) (91)
- Effects of Rifaximin Treatment and Retreatment in Nonconstipated IBS Subjects (2011) (91)
- Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials (2014) (90)
- Microbiome and Its Role in Irritable Bowel Syndrome (2020) (83)
- Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. (2001) (81)
- T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained Response (2008) (80)
- Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome (2015) (80)
- A New Rat Model Links Two Contemporary Theories in Irritable Bowel Syndrome (2008) (78)
- Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? (2014) (77)
- A Combination of Rifaximin and Neomycin Is Most Effective in Treating Irritable Bowel Syndrome Patients With Methane on Lactulose Breath Test (2009) (77)
- Review of rifaximin as treatment for SIBO and IBS. (2009) (72)
- Evaluating Breath Methane as a Diagnostic Test for Constipation-Predominant IBS (2010) (72)
- Methanogens in Human Health and Disease (2012) (71)
- Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model (2015) (70)
- A 14-Day Elemental Diet Is Highly Effective in Normalizing the Lactulose Breath Test (2004) (69)
- Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea (2016) (68)
- Increased Prevalence of Irritable Bowel Syndrome in Patients With Gastroesophageal Reflux (2002) (68)
- Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption (2003) (68)
- Gas and the Microbiome (2013) (66)
- Evaluation of harm in the pharmacotherapy of irritable bowel syndrome. (2012) (66)
- IBS Subjects with Methane on Lactulose Breath Test Have Lower Postprandial Serotonin Levels Than Subjects with Hydrogen (2004) (66)
- Peppermint Oil Improves the Manometric Findings in Diffuse Esophageal Spasm (2001) (64)
- Lactose Intolerance and the Role of the Lactose Breath Test (2010) (61)
- Efficacy of the glucagon‐like peptide‐1 agonist exenatide in the treatment of short bowel syndrome (2011) (60)
- Bacteria and irritable bowel syndrome: The evidence for small intestinal bacterial overgrowth (2006) (58)
- Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders (2015) (57)
- Pathogen-Specific Risk of Celiac Disease Following Bacterial Causes of Foodborne Illness: A Retrospective Cohort Study (2013) (56)
- Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis (2000) (55)
- Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome (2012) (55)
- Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update (2020) (54)
- AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review. (2020) (54)
- Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome (2012) (52)
- Intestinal Methanobrevibacter smithii but not total bacteria is related to diet‐induced weight gain in rats (2012) (52)
- Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness (2013) (52)
- Measuring response in the gastrointestinal tract in systemic sclerosis (2013) (52)
- Antibiotics for the treatment of irritable bowel syndrome. (2011) (49)
- Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome (2018) (48)
- Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III (2012) (48)
- In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth. (2014) (46)
- ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS. (2010) (45)
- Antibiotics for Irritable Bowel Syndrome: Rationale and Current Evidence (2012) (42)
- Report from the multinational irritable bowel syndrome initiative 2012. (2013) (41)
- The duodenal microbiome is altered in small intestinal bacterial overgrowth (2020) (39)
- Mapping the Segmental Microbiomes in the Human Small Bowel in Comparison with Stool: A REIMAGINE Study (2020) (39)
- Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome (2014) (38)
- Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity (2017) (38)
- The Effect of Rifaximin on Gut Flora and Staphylococcus Resistance (2013) (37)
- Review of rifaximin as treatment for SIBO and IBS (2009) (37)
- Esophageal motor dysfunction and gastroesophageal reflux are prevalent in lung transplant candidates. (2010) (37)
- Estimating the Contribution of Acute Gastroenteritis to the Overall Prevalence of Irritable Bowel Syndrome (2012) (37)
- Visceroptosis of the bowel in the hypermobility type of Ehlers-Danlos syndrome: presentation of a rare manifestation and review of the literature. (2012) (37)
- Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage (2016) (36)
- Polycystic Ovary Syndrome Is Associated with an Increased Prevalence of Irritable Bowel Syndrome (2010) (36)
- Biomarkers of Irritable Bowel Syndrome (2017) (35)
- Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome (2017) (34)
- Irritable bowel syndrome and small intestinal bacterial overgrowth. (2010) (34)
- Gender distribution in irritable bowel syndrome is proportional to the severity of constipation relative to diarrhea. (2010) (33)
- Inflammation and microflora. (2011) (33)
- Proton Pump Inhibitor Therapy Does Not Affect Hydrogen Production on Lactulose Breath Test in Subjects with IBS (2010) (33)
- Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth. (2009) (33)
- Ultraviolet A light effectively reduces bacteria and viruses including coronavirus (2020) (33)
- New Clinical Method for Distinguishing D-IBS from Other Gastrointestinal Conditions Causing Diarrhea: The LA/IBS Diagnostic Strategy (2008) (32)
- Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea (2019) (32)
- Gut Microbiota Dysbiosis in Functional Dyspepsia (2020) (31)
- Do Jackhammer contractions lead to achalasia? A longitudinal study (2017) (31)
- Irritable bowel syndrome: Bacterial overgrowth—What’s known and what to do (2007) (31)
- Acute and Chronic Histological Changes of the Small Bowel Secondary to C. jejuni Infection in a Rat Model for Post-Infectious IBS (2011) (31)
- Age and the aging process significantly alter the small bowel microbiome. (2021) (30)
- Apple Sauce Improves Detection of Esophageal Motor Dysfunction During High-Resolution Manometry Evaluation of Dysphagia (2010) (30)
- Evaluating a Bacterial Hypothesis in IBS Using a Modification of Koch’s Postulates: Part 1 (2010) (30)
- Redefining the role of lymphocytes in gastroesophageal reflux disease and eosinophilic esophagitis. (2010) (28)
- Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. (2018) (28)
- Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial bowel changes (2013) (27)
- Breath Testing for Small Intestinal Bacterial Overgrowth: Should We Bother? (2016) (27)
- Metabolic effects of eradicating breath methane using antibiotics in prediabetic subjects with obesity (2016) (25)
- Bacterial concepts in irritable bowel syndrome. (2005) (24)
- Evidence-based management of irritable bowel syndrome with diarrhea. (2018) (24)
- Adverse events appear to unblind clinical trials in irritable bowel syndrome (2014) (23)
- Severity of Dyspeptic Symptoms Correlates with Delayed and Early Variables of Gastric Emptying (2012) (23)
- Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption. (2003) (23)
- Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. (2000) (21)
- Small Intestinal Bacterial Overgrowth: A Possible Association with Fibromyalgia (2001) (21)
- Is small intestinal bacterial overgrowth involved in the pathogenesis of functional dyspepsia? (2017) (21)
- Can three‐dimensional high‐resolution anorectal manometry detect anal sphincter defects in patients with faecal incontinence? (2017) (20)
- Supporting long-term educational activities through dynamic web interfaces (2001) (20)
- Color Atlas of High Resolution Manometry (2009) (19)
- Evaluation of peripapillary lymphocytosis and lymphocytic esophagitis in adult inflammatory bowel disease. (2013) (19)
- Postprandial Improvement of Gastric Dysrhythmias in Patients with Type II Diabetes (2001) (19)
- Dyssynergic Defecation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. (2018) (18)
- Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial (2017) (18)
- Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels (2019) (18)
- Relationships Among the Lactulose Breath Test, Intestinal Gas Volume, and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome (2011) (18)
- Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study (2019) (18)
- “Pre-cebo”: An Unrecognized Issue in the Interpretation of Adequate Relief During Irritable Bowel Syndrome Drug Trials (2012) (17)
- Rifaximin, a Non-Absorbable Antibiotic, Improves the Symptoms of Irritable Bowel Syndrome: A Double-Blind Randomized Controlled Study (2005) (17)
- Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome (2021) (17)
- The prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome: IBS vs healthy controls (not historical definitions). (2008) (17)
- An Evidence-Based Treatment Algorithm for IBS Based on a Bacterial/SIBO Hypothesis: Part 2 (2010) (16)
- Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway (2016) (15)
- An Approach to the Patient With Chronic Undiagnosed Abdominal Pain (2019) (15)
- Factor Analysis Demonstrates a Symptom Cluster Related to Methane and Non-methane Production in Irritable Bowel Syndrome (2011) (15)
- Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes (2021) (15)
- T1411 Predictors of Clinical Response from a Phase 2 Multi-Center Efficacy Trial Using Rifaximin, a Gut-Selective, Nonabsorbed Antibiotic for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome (2008) (15)
- Methane-producing human subjects have higher serum glucose levels during oral glucose challenge than non-methane producers: a pilot study of the effects of enteric methanogens on glycemic regulation (2014) (14)
- Influence of Dietary Restriction on Irritable Bowel Syndrome (2018) (14)
- 475i Rifaximin Treatment for 2 Weeks Provides Acute and Sustained Relief Over 12 Weeks of IBS Symptoms in Non-Constipated Irritable Bowel Syndrome: Results From 2 North American Phase 3 Trials (Target 1 and Target 2) (2010) (14)
- Accurate Identification of Excessive Methane Gas Producers by a Single Fasting Measurement of Exhaled Methane: A Large-scale Database Analysis ACG Category Award: 1787 (2015) (14)
- Antibiotic Prophylaxis Prevents the Development of a Post-Infectious Phenotype in a New Rat Model of Post-Infectious IBS (2011) (13)
- 267 The First Large Scale Deep Sequencing of the Duodenal Microbiome in Irritable Bowel Syndrome Reveals Striking Differences Compared to Healthy Controls (2013) (13)
- Acute appendicitis is associated with appendiceal microbiome changes including elevated Campylobacter jejuni levels (2020) (12)
- Healthy control subjects are poorly defined in case-control studies of irritable bowel syndrome (2015) (12)
- Issue Information ‐ Table of Contents (2016) (12)
- Evaluating the functional net value of pharmacologic agents in treating irritable bowel syndrome (2014) (12)
- A High-resolution View of Achalasia (2009) (12)
- High Prevalence of Small Intestinal Bacterial Overgrowth among Functional Dyspepsia Patients (2020) (12)
- Intestinal methane production is associated with decreased weight loss following bariatric surgery. (2016) (10)
- Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin (2016) (10)
- Eradication of small intestinal bacterial overgrowth decreases symptoms in chronic fatigue syndrome: A double blind, randomized study (2000) (10)
- Comparison of peak breath hydrogen production in patients with irritable bowel syndrome,chronic fatigue syndrome and fibromyalgia (2000) (9)
- A Predictive Model to Estimate Cost Savings of a Novel Diagnostic Blood Panel for Diagnosis of Diarrhea-predominant Irritable Bowel Syndrome. (2016) (9)
- Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes (2022) (9)
- Tu2110 Circulating Antibodies to Cytolethal Distending Toxin B Correlate With the Development of Small Intestinal Bacterial Overgrowth in a Rat Model of Post-Infectious IBS (2013) (9)
- Do antibiotics influence IBS? (2002) (7)
- Su1210 SYN-010, a Proprietary Modified-Release Formulation of Lovastatin Lactone, Lowered Breath Methane and Improved Stool Frequency in Patients With IBS-C: Results of a Multi-Center Randomized Double-Blind Placebo-Controlled Phase 2a Trial (2016) (7)
- Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea (2020) (7)
- Small Bowel Culture Confirms the Presence of Small Intestinal Bacterial Overgrowth in a Subset of IBS Subjects (2011) (7)
- Comparing the rates of methane production in patients with and without appendectomy: results from a large-scale cohort (2020) (7)
- Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts (2020) (7)
- Mo1865 Prevalence of Excessive Intestinal Methane Production and Its Variability With Age and Gender: A Large-Scale Database Analysis (2015) (7)
- Measurement of Hydrogen Sulfide during Breath Testing Correlates to Patient Symptoms (2017) (6)
- Mo1864 Understanding the Significant Interaction Between Hydrogen and Methane in the Performance and Interpretation of Breath Testing (2015) (6)
- Understanding Breath Tests for Small Intestinal Bacterial Overgrowth. (2016) (6)
- Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome (2020) (6)
- Impact Of A Novel Ibs Diagnostic Blood Panel For Mexico: Cost Implications To The Mexican Private Practice For Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D). (2015) (6)
- Irritable Bowel Syndrome in Pregnancy. (2021) (6)
- A Single Fasting Exhaled Methane Level Correlates With Fecal Methanogen Load, Clinical Symptoms and Accurately Detects Intestinal Methanogen Overgrowth (2022) (6)
- Comprar Color Atlas of High Resolution Manometry | Conklin, Jeffrey | 9780387882925 | Springer (2009) (6)
- 182 - Competitive Hydrogen Gas Utilization by Methane- and Hydrogen Sulfide-Producing Microorganisms and Associated Symptoms: Results of a Novel 4-Gas Breath Test Machine (2018) (5)
- Lovastatin Lactone Inhibits Methane Production in Human Stool Homogenates: 1771 (2015) (5)
- Mo1268 Characterization of Stool Microbiota in Subjects With IBS-D Receiving Repeat Treatments With Rifaximin in the TARGET 3 Study (2015) (5)
- Prevention of traveler's diarrhea: a call to reconvene. (2008) (5)
- Breath Testing for Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Metaanalysis: 1794 (2015) (5)
- In the Treatment of IBS, the Clinical Response to Rifaximin Is Deteremined by the Normalization of the Lactulose Breath Test: 1223 (2006) (5)
- Sa1911 – Analysis of the Small Intestinal Microbiome Reveals Marked Differences from Stool Microbiome in a Large Scale Human Cohort: Redefining the “Gut Microbiome” (2019) (5)
- Serum sTREM-1 as a Surrogate Marker of Treatment Outcome in Patients with Peptic Ulcer Disease (2011) (5)
- Smoking has disruptive effects on the small bowel luminal microbiome (2022) (5)
- Essential Medical Disorders of the Stomach and Small Intestine (2019) (5)
- Gastroesophageal Reflux Reported on Esophagram Does Not Correlate with pH Monitoring and High-resolution Esophageal Manometry (2014) (5)
- Mo2026 Methane on Breath Test Predicts Altered Rectal Sensation During High Resolution Anorectal Manometry (2014) (4)
- 4 – First Large Scale Study Defining the Characteristic Microbiome Signatures of Small Intestinal Bacterial Overgrowth (SIBO): Detailed Analysis from the Reimagine Study (2019) (4)
- 450 Hydrogen- and Methane- Based Breath Testing (BT) in Gastrointestinal (GI) Disorders: Report of the North American Consensus Meeting (2016) (4)
- T2085 Methane on Breath Testing is Associated With Constipation: A Systematic Review and Meta-Analysis (2010) (4)
- Tu2029 Deep Sequencing Reveals That the Microbiome of the Human Duodenum Is Unique and Unrelated to Stool Bacterial Profiling (2013) (4)
- The Prevalence of Irritable Bowel Syndrome in Patients With Typical Symptoms Referred to the Gastroenterologist: A Systematic Review: 1783 (2015) (4)
- Tu2030 Quantitation of Bacteria in Duodenal Aspirates by qPCR Appears to Identify Viable Organisms in IBS (2013) (4)
- Do antibiotics influence IBS (2002) (4)
- Inclusion Of A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): A Uk Perspective. (2015) (4)
- Small Intestinal Bacterial Overgrowth (2015) (4)
- Probiotics for antibiotic-associated diarrhea: PLACIDE swings the pendulum. (2014) (4)
- Mo1879 Natural Manometric Course of Jackhammer Esophagus and Its Determinants -A Large-Scale Database Analysis (2014) (4)
- History of tonsillectomy is associated with irritable bowel syndrome. (2011) (4)
- Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis (2019) (3)
- Gastrointestinal Infection with Campylobacter jejuni 81–176 Produces Altered Bowel Function and Bacterial Overgrowth in Rats: 1216 (2006) (3)
- A definitive blood test for post-infectious irritable bowel syndrome? (2016) (3)
- Corrigendum: Lactose Intolerance and the Role of the Lactose Breath Test (2010) (3)
- The Treatment of Patients With Irritable Bowel Syndrome: Review of the Latest Data From the 2010 DDW Meeting. (2010) (3)
- 439 Methanobrevibacter Smithii is Found in Human Duodenum and is Associated With Altered Luminal Cytokines (2012) (3)
- Duodenal microbiome changes in postmenopausal women: effects of hormone therapy and implications for cardiovascular risk (2022) (3)
- Response to Dr. Parisi et al. (2003) (3)
- Update on Irritable Bowel Syndrome Diagnostics and Therapeutics. (2016) (3)
- Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway. (2016) (3)
- Mo1279 Durability of Benefit in IBS-D Patients Responding to a 2-Week Course of Rifaximin: Results From TARGET 3 (2015) (3)
- Intestine Microbes in Gastroenterology: Health and Disease (2012) (3)
- Concomitant Methane and Hydrogen Production in Humans is Associated With a Higher Body Mass Index (2011) (3)
- Tu1403 Safety and Tolerability Profile of Rifaximin for Treatment of IBS Without Constipation: Results of a Pooled Analysis of Double-Blind, Placebo-Controlled Randomized Controlled Trials (2012) (3)
- Sa1105 International Perceptions of IBS: Survey of IBS Investigators From the Global Multinational IBS Initiative (2013) (2)
- Autoimmunity as a Potential Cause of Post-Infectious Gut Dysmotility: A Longitudinal Observation (2017) (2)
- Importance of Diarrhea in Evaluating Constipation in Irritable Bowel Syndrome Clinical Studies (2011) (2)
- Sa1219 - Validation of a 4-Gas Device for Breath Testing in the Determination of Small Intestinal Bacterial Overgrowth (2018) (2)
- The small bowel microbiome changes significantly with age and aspects of the ageing process (2021) (2)
- S1326 Presumed IBS Subjects With Short Remission After Antibiotic Therapy Often Have Secondary Causes for Their Symptoms (2010) (2)
- Print and Digital Media Review (2015) (2)
- Bile Acid and Gut Microbiota in Irritable Bowel Syndrome (2022) (2)
- Mo1261 Characterizing the Effect of Rifaximin on Individual Symptoms of IBS-D: Findings From the Open-Label Phase of TARGET 3 (2015) (2)
- Fr248 EXHALED HYDROGEN SULFIDE IS INCREASED IN PATIENTS WITH DIARRHEA: RESULTS OF A NOVEL COLLECTION AND BREATH TESTING DEVICE (2021) (2)
- W1367 Intestinal Methane Production in Obese Humans is Associated With Higher Body Mass Index (2010) (2)
- Pathogen-specific Risk of Functional Gastrointestinal Disorders, Gastroesophageal Reflux Disease and Celiac Disease Following Acute Enteric Infection: 1337 (2011) (2)
- Eradication of small intestinal bacterial overgrowth decreases the gastrointestinal symptoms in fibromyalgia (2000) (2)
- Anti-vinculin Antibodies: Multicenter Validation of a Diagnostic Blood Test for Irritable Bowel Syndrome: ACG Governors Award for Excellence in Clinical Research: 1887 (2013) (2)
- Atlas of High-Resolution Manometry, Impedance, and pH Monitoring (2019) (2)
- Mo1269 Enduring Effects Following a Course of Rifaximin Therapy in Patients With IBS-D: Incremental Benefit Upon Repeat Treatment (2015) (2)
- Ultraviolet-A light increases mitochondrial anti-viral signaling protein in confluent human tracheal cells even at a distance from the light source (2021) (2)
- Identifying and testing candidate genetic polymorphisms in irritable bowel syndrome: association with TNFSF15 and tumor necrosis factor-α (2013) (2)
- Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study (2021) (2)
- Clinical Approach to Non-Ulcer Dyspepsia (1999) (2)
- Time to Onset and Durability of Relief in Non-Constipation IBS Patients Over 12 Weeks Following a 2-Week Course of Rifaximin (2011) (2)
- Small Intestine Bacterial Overgrowth Can Form an Indigenous Proinflammatory Environment in the Duodenum: A Prospective Study (2022) (2)
- Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. (2020) (2)
- Sa1158 The Number of Drug Side Effects Is Associated With Greater Efficacy in IBS Clinical Trials: The Potential Influence of Unblinding (2013) (2)
- W1938 Antibody to Cytolethal Distending Toxin of Campylobacter Jejuni Stains Small Bowel Myenteric Neuromuscular Elements in Control and C. Jejuni Exposed Rats: A Possible Role of Molecular Mimicry (2010) (2)
- Tu1804 Anti-Vinculin and Anti-CdtB Antibodies in Mexican Subjects: A Case Control Study (2016) (2)
- 1089 - A Novel 4-Gas Device for Breath Testing Shows Exhaled H2S is Associated with Diarrhea and Abdominal Pain in a Large Scale Prospective Trial (2018) (2)
- M1154 Fatigue and Abdominal Bloating Predict Small Intestinal Bacterial Overgrowth (SIBO) in Patients with Ulcerative Colitis (UC) (2008) (2)
- Ultraviolet-A light reduces cellular cytokine release from human endotracheal cells infected with Coronavirus (2021) (2)
- Functional and GI Motility Disorders, E.M.M. Quigley, M. Hongo, S. Fukudo (Eds.). Karger, Basel, Switzerland (2014), 176 www.karger.com, $209, ISBN: 978-3-318-02578-1. Web address for ordering: (2015) (2)
- Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway. (2017) (2)
- Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. (2020) (1)
- Rifaximin Repeat Treatment in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Produced No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity: 1790 (2015) (1)
- Mo2051 Lovastatin Improves Stool Form in Methanobrevibacter Smithii Colonized Rats With Constipation (2015) (1)
- S543 Validation of Novel Mobile App Using Artificial Intelligence to Capture and Objectively Characterize Stool Images in a Clinical Trial (2021) (1)
- The Efficacy of the GLP-1 Agonist Exenatide in the Treatment of Short Bowel Syndrome: 233 (2007) (1)
- Validation of an objective bowel composite score for IBS in studies involving treatment (2002) (1)
- The Effect of Dried Plum on Targeted Gut Flora and Host Gene Expression in a Rat Model of Post-infectious IBS: 1815 (2014) (1)
- Healthy Controls Are Not Appropriately Identified for Comparison to Irritable Bowel Syndrome in Case Control Studies (2011) (1)
- Mo1314 Effect of Rifaximin Treatment on Anti-Vinculin Antibodies in IBS With Diarrhea (2016) (1)
- Rectal Hypersensitivity in Patients with Irritable Bowel Syndrome Compared to Healthy Control: A Systemic Review of Literature: 1755 (2012) (1)
- Sa1339 A Comparison of Psychological Associations With IBS and Ulcerative Colitis (2013) (1)
- Case studies of antibiotic therapy in the management of functional gastrointestinal disorders. (2007) (1)
- A Systematic Review of Diagnostic Testing for Small Intestinal Bacterial Overgrowth: 235 (2007) (1)
- Tu1390 Improvement in Quality of Life of Patients With Irritable Bowel Syndrome With Diarrhea is Sustained for 10 Weeks Following a 2-Week Course of Rifaximin (2012) (1)
- Irritable Bowel Syndrome: Pathophysiology and Goals of Therapy (2020) (1)
- Tu1406 Impact of Concurrent use of PPIs or Anti-Depressants on Efficacy of Rifaximin for IBS Without Constipation (2012) (1)
- Su1194 - Efficacy of Rifaximin in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Prior use of IBS Medications (2018) (1)
- Recorded Lower Esophageal Pressures as a Function of Electronic Sleeve Placement and Location of Gastric Pressure Measurement in Patients With Hiatal Hernia (2013) (1)
- Response to Dr. Riordan et al. (2001) (1)
- Methane Production in IBS Subjects Is Associated with a Constellation of Symptoms: Not Just Constipation: 1039 (2007) (1)
- Correction: Ultraviolet A light effectively reduces bacteria and viruses including coronavirus (2020) (1)
- A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): Cost Implications For Denmark. (2015) (1)
- A Smartphone Application Using Artificial Intelligence Is Superior To Subject Self-Reporting When Assessing Stool Form (2022) (1)
- Safety and Tolerability of High-Resolution Esophageal Manometry: A Large Database Analysis (2017) (1)
- Mo1641 Efficacy and Tolerability of Linaclotide and Plecanatide in Treating Irritable Bowel Syndrome With Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC): A Meta-Analysis (2016) (1)
- Sa1216 - The Convergence of Bacterial Overgrowth, Systemic Inflammatory Biomarkers, and Anti-Vinculin Antibodies in Determining the Response to Rifaximin Treatment in Diarrhea-Predominant Ibs (D-Ibs) Subjects (2018) (1)
- T1832 Methanobrevibacter Smithii is Prominent in Stool of Subjects With Constipation Predominant IBS and Methane on Lactulose Breath Test (2010) (1)
- Cost Savings Associated With Rifaximin for Diarrhea-Predominant Irritable Bowel Syndrome (2012) (1)
- Basic Principles of Ambulatory pH Monitoring and Impedance (2019) (1)
- S1878 Epithelial Lymphocytosis Is Prevalent in Both Reflux and Eosinophilic Esophagitis (2009) (1)
- Phenotype and Antibiotic Response in Patients With Flat Line Breath Test Results: A Large Scale Database Analysis (2018) (1)
- 979 – A Large Scale Evaluation of the Small Intestinal Microbiome in Subjects on Proton Pump Inhibitors (2019) (1)
- Identification of Rumination with Impedance Manometry and High-Resolution Manometry: 71 (2008) (1)
- Rifaximin Is Superior to Other Antibiotics in Treating and Retreating Bacterial Overgrowth in IBS, Supporting a Lack of Bacterial Resistance Development: 1224 (2006) (1)
- Tu1418 Physiologic Esophageal Length in Adults Is Associated With Gender and Presence of Hiatal Hernia but Not With Age (2015) (1)
- Sa1912 – Revealing the Entire Intestinal Microbiota and Its Associations to the Genetic, Immunologic, and Neuroendocrine Ecosystems: Methodology for the Reimagine Study (2019) (1)
- 1039 Functional Net Value (FNV): an Important Consideration in Clinical Evaluation of IBS Pharmacotherapy (2012) (1)
- 169: EXAMINING THE ROLE OF SULFATE REDUCING BACTERIA AND METHANOGENS ON MICROBIOME, SYMPTOMS, AND BREATH TESTING IN IBS-D AND IBS-C (2022) (1)
- Tu1887 – Patients with Appendectomy Have Significantly Less Methane in Their Exhaled Breath: is the Appendix a Vestigial Organ Or an Important Reservoir for Methanogens? (2019) (1)
- Unique Differences in Breath Test Gas Patterns in Inflammatory Bowel Disease (IBD) Compared to Non-IBD Patients: A Large-Scale Database Linkage Analysis (2018) (1)
- Endotracheal application of ultraviolet A light in critically ill severe acute respiratory syndrome coronavirus-2 patients: A first-in-human study (2021) (1)
- Lymphocytic Esophagitis is Uncommon in Adult Inflammatory Bowel Disease (2011) (1)
- Editorial: safety and tolerability of rifaximin for IBS – more information is required; authors' reply (2014) (1)
- Daily Variation of Bowel Habits Predicts a Diagnosis of IBS Among Patients Referred to a General Gastroenterologist for Evaluation of Chronic Diarrhea: Validation of the LA/IBS Diagnostic Strategy (2011) (1)
- Sa1909 – Deep Sequencing of the Entire Human Small Intestine: A Comparison to Stool Microbiome in the Reimagine Study (2019) (1)
- Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity (2017) (1)
- Methane-Producing Subjects Have Higher Serum Glucose Levels During Oral Glucose Challenge Than Non-Methane Producers (2011) (1)
- Su544 SMOKING CHANGES THE SMALL BOWEL MICROBIOME BUT APPEARS REVERSIBLE WITH SMOKING CESSATION COMPARED TO CONTROL SUBJECTS: RESULTS FROM THE REIMAGINE STUDY (2021) (1)
- Declining Rates of Referral for Irritable Bowel Syndrome Without Constipation at a Tertiary Care Center (2018) (1)
- Interleukin-10 knockout mice do not reliably exhibit macroscopic inflammation: a natural history endoscopic surveillance study (2021) (1)
- Cytolethal Distending Toxin B (CdtB) Exposure Alone is Sufficient to Precipitate Autoimmunity and Changes to the Small Intestinal Microbiome in a Rat Model of Post-Infectious IBS (2017) (1)
- Sa1742 – Interleukin-10 Knockout Mice Do Not Exhibit Persistent Leftsided Colitis: A Natural History Endoscopic Surveillance Study (2019) (1)
- Lactulose Breath Testing Predicts the Response to Rifaximin: 423 (2017) (1)
- Su1949 – Small Intestinal Aspirates Require Specific Treatment to Optimize Microbial Analysis: Validation of a Novel Technique from the Reimagine Study (2019) (1)
- The presence of constipation and methane on lactulose breath test in ibs subjects is associated with lower serotonin levels compared to hydrogen alone (2003) (0)
- Sa2046 Utility of Anorectal Manometry and Anal Ultrasound in Evaluation of Fecal Incontinence (2013) (0)
- Anti-vinculin antibodies in systemic sclerosis: associations with slow gastric transit and extra-intestinal clinical phenotype. (2023) (0)
- Editorial: The methane moment - Cross-boundary significance of methanogens: Preface (2022) (0)
- Mo1319 Syn-010, a Proprietary Modified-Release Formulation of Lovastatin Lactone, May Improve Constipation by Inhibiting Enzymes in the Archaeal Methanogenesis Pathway: Results of Computational M. Smithii Enzyme-Ligand Docking Experiments (2016) (0)
- Incontinence and Anal Sphincter Pressure Predicts Rectal Sensitivity During High Resolution Anorectal Manometry: 1300 (2009) (0)
- Does Bacterial Overgrowth Affect Breath Alcohol Levels on DUI Testing?: 2016 ACG Presidential Poster Award: 1072 (2016) (0)
- Su1891 Evaluation of High-Resolution Esophageal Manometry, Gastrointestinal Symptoms, and Pulmonary Disease in Scleroderma (2013) (0)
- Tu1383: SUBCUTANEOUS INOCULATION WITH CYTOLETHAL DISTENDING TOXIN B IN A RAT MODEL OF POST-INFECTIOUS IBS PRODUCES PROFOUND CHANGES IN THE SMALL BOWEL MICROBIOME (2022) (0)
- Evaluating Breath Methane as a Diagnostic Test for Constipation Predominant IBS: 1174 (2008) (0)
- M1238 The Severity of Diarrhea and Constipation Are Important in Examining Gender Differences in IBS (2009) (0)
- Mo1338 A POOLED ANALYSIS OF TWO PHASE 3, PLACEBO-CONTROLLED STUDIES ASSESSING THE IMPACT OF COLONOSCOPY TIMING ON RIFAXIMIN EFFICACY IN IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) (2020) (0)
- 1134 The Utility of Measuring Anti-Cytolethal Distending Toxin B and Anti-Vinculin Antibodies in a Tertiary Care Motility Practice: A Free Range Experience (2016) (0)
- Declining Rates of Referral to Tertiary Care Center for IBS-D (2017) (0)
- Development and Seroconversion of Anti-Cytolethal Distending Toxin(CdtB) and Anti-Vinculin Antibodies in a Patient with Evolving Post-infectious IBS: 1693 (2016) (0)
- Su1612: MARKED CHANGES ARE SEEN IN THE SMALL BOWEL MICROBIOME AS A RESULT OF THE COVID-19 PANDEMIC (2022) (0)
- Validating a New Genomic Test for Irritable Bowel Syndrome (2011) (0)
- Mo1311 Evaluating the Safety and Efficacy of Eluxadoline for Treating Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis (2016) (0)
- “Stack of Coins” on Manometry: Type 3 Achalasia Complicated by Severe Esophageal Diverticulosis: 609 (2015) (0)
- Responsiveness of a Tri-Component Endpoint in Non-Constipation Irritable Bowel Syndrome: Pooled Results from Two Phase 3 Trials, TARGET 1 and TARGET 2: 1750 (2012) (0)
- Tu1990 Expression of Mucosal Defense Mediators and Cytokines are Dependent on the Number of Exposures to C. Jejuni in a Rat Model of Post-Infectious IBS (2012) (0)
- Exhaled Methane Is Associated with a Lower Heart Rate (2021) (0)
- Effectiveness of Rifaximin for Symptomatic Relief of Irritable Bowel Syndrome (2011) (0)
- Mo1552 AN ANALYSIS OF PLACEBO RATE AND FRAGILITY INDEX FOR ANTIDEPRESSANTS AS TREATMENTS FOR IRRITABLE BOWEL SYNDROME (2020) (0)
- Lactulose Breath Testing Predicts Response to Rifaximin for Cardinal Irritable Bowel Syndrome With Diarrhea (IBS-D) (2018) (0)
- Su1201 DIFFERENCES IN SMALL INTESTINAL MICROBIOME PATTERNS IN HISPANIC AND NON-HISPANICS IN THE GREATER LOS ANGELES AREA: RESULTS FROM THE REIMAGINE STUDY (2020) (0)
- T1236 Apple Sauce Improves the Detection of Abnormal Esophageal Motor Function During High Resolution Manometry Evaluation of Dysphagia (2009) (0)
- Its modulation by the methane concentration in the gut (2003) (0)
- Sa1102: PATIENTS WITH IBS HAVE A LOWER PREVALENCE OF COLORECTAL POLYPS AND CANCER DURING COLONOSCOPY: A SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (0)
- Anorectal Manometry (2019) (0)
- Antibiotic Susceptibility of Skin Swab Staphylococcus Isolates From Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Treated With Repeat Courses of Rifaximin Showed No Evidence of Resistance: 1767 (2015) (0)
- Dyssynergic Defecation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis: 766 (2017) (0)
- Tu1910 SUBJECTS ON A GLUTEN-FREE DIET HAVE SIGNIFICANT CHANGES IN THE SMALL BOWEL MICROBIOME ASSOCIATED WITH LOWER TNFα LEVELS: RESULTS FROM THE REIMAGINE STUDY (2020) (0)
- Mo1042 Evaluation of Treatment-Associated Harm for Irritable Bowel Syndrome With Constipation (2012) (0)
- Rifaximin and Neomycin in the Treatment of Constipation IBS with Methane as a Biomarker on Breath Testing: Presidential Poster: 1864 (2013) (0)
- W1283 Antibiotics and Cdt Expression in Campylobacter Jejuni Contribute to Duration of Colonization in Rats (2008) (0)
- Sa604 THE STOOL MICROBIOME IN POLYCYSTIC OVARY SYNDROME (PCOS) SUBJECTS IS DISTINCT FROM THAT OF NON-PCOS CONTROLS (2021) (0)
- SAT0251 Vascular Involvement in Scleroderma; Phenotypic Variability with Different Mechanistic Pathways (2016) (0)
- Procédés de traitement du syndrome du côlon irritable (2014) (0)
- S500 Presence of Methane in the Fasting Breath Is Associated With a Lower Rise in Pancreatic Polypeptide After Modified Sham-Feeding: An Insight into the Connection Between Vagal Dysfunction and Methane (2021) (0)
- P008 Clinical Applicability of Anti-CdtB and Anti-Vinculin Antibodies to Diagnose Superimposed Irritable Bowel Syndrome in Inflammatory Bowel Disease Patients (2019) (0)
- Mo1053 Systematic Review of Diagnostic Criteria for IBS Demonstrates Poor Validity and Utilization of ROME III (2012) (0)
- Expression of B-Defensin-2 and Other PRO-Inflammatory Mediators Notable in IBS Are Increased in Rat Mucosa During Acute Campylobacter Jejuni Infection (2011) (0)
- PRIMARY TUBULAR TESTICULAR INSUFFICIENCY. (1964) (0)
- Examination of the effects of breath hydrogen and methane levels on the EC/IR II (2017) (0)
- The Methanobrevibacter smithii Concentration in Stool of Subjects with Constipation Predominant IBS is Directly Correlated with Methane on Lactulose Breath Test: 1352 (2010) (0)
- Nightly Tegaserod Prevents the Clinical Recurrence of Bacterial Overgrowth Symptoms: 1038 (2007) (0)
- 311 Large Scale Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome (2015) (0)
- Sa1644: COMPREHENSIVE CHARACTERIZATION OF THE GASTROINTESTINAL LUMINAL ARCHAEOME: DATA FROM THE REIMAGINE STUDY (2022) (0)
- 276: ASSESSMENT OF STOOL IMAGES USING ARTIFICIAL INTELLIGENCE VIA A SMARTPHONE APPLICATION IS MORE ACCURATE THAN PATIENT REPORTED OUTCOMES (2022) (0)
- 1023 - Cytokine Profiles Before and after Rifaximin Treatment Appear to Differ in Responders and Non-Responders to Treatment in D-Ibs (2018) (0)
- S499 Elevations in Breath Methane Are Associated With Lower Heart Rate: Post-Hoc Analysis of a Double Blind Randomized Control Trial (2021) (0)
- Mathematical Modeling Estimates the Impact of Acute Gastroenteritis on the Development of IBS in the U.S. (2011) (0)
- Improvements over Time in Individual Diarrhea-Predominant Irritable Bowel Syndrome Symptoms (IBS-D) with Rifaximin Repeat Treatment: 530 (2016) (0)
- Su1191 - Efficacy of Rifaximin on Bloating in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Pooled Analysis of Three Phase 3, Randomized, Placebo-Controlled Trials (2018) (0)
- Tu1567: THE SMALL BOWEL MICROBIOME DEMONSTRATES STABILITY OVER TIME: DATA FROM THE REIMAGINE STUDY (2022) (0)
- Tu1251 - Antibodies to Campylobacter Jejuni-Derived Cytolethal Distending Toxin B and Human Vinculin Localize to the Gastrointestinal Tract after In Vivo Acute Administration (2018) (0)
- The Responsiveness and Validity of a Binary Weekly Recall Question and the Proposed FDA Composite Endpoint as Measures of Daily Symptom Severity in Non-Constipation Irritable Bowel Syndrome: Results of TARGET 1 and TARGET 2: 1337 (2010) (0)
- Sa1900 – Interobserver Agreement Among Endoscopists in Evaluating Colonic Inflammation in Mice (2019) (0)
- SAFETY AND TOLERABILITY OF HIGH-RESOLUTION ESOPHAGEAL MANOMETRY IN CHILDREN AND ADULTS. (2023) (0)
- Sa1215 USING A NOVEL 4-GAS BREATH TEST DEVICE, MULTIVARIABLE ANALYSIS REVEALS AN ASSOCIATION BETWEEN EXCESSIVE HYDROGEN SULFIDE ON BREATH TESTING AND HEARTBURN (2020) (0)
- Safety and Tolerability of Rifaximin in the Treatment of Irritable Bowel Syndrome (IBS): A Pooled Analysis of 4 Randomized, Placebo-Controlled Trials: 555 (2016) (0)
- Su1424 Evaluating the Role of Cytolethal Distending Toxin in the Development of Small Intestinal Bacterial Overgrowth in a Rat Model of Post-Infectious IBS (2014) (0)
- Mo2011 – Small Intestinal Microbial Shifts Towards Bile-Tolerantassociated-Microbiota and Increases in Bile Acids are Seen After Endobarrier® Implantation in a Canine Model (2019) (0)
- Significant Overlap between IBS and GERD: A Systematic Review of Literature (2005) (0)
- Campylobacter infection and the link with Irritable Bowel Syndrome: on the pathway towards a causal association. (2022) (0)
- Tu1076 Predictive Value of Adequate Relief of Global IBS Symptoms During First Two Weeks of Rifaximin use on Subsequent Relief of Daily IBS Symptoms and Daily Bloating Symptoms (2012) (0)
- Fiber Wars: Are mixed soluble and insoluble fibers the answer for irritable bowel syndrome? (2021) (0)
- Su1195 - Rifaximin Repeat Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Impact on Clostridium Difficile Infection Development (2018) (0)
- Antibodies to an 18-Residue Peptide of Cdt Are Found in the Serum of Rats in a Model of Post-Infectious IBS (2011) (0)
- S525 Serum IgA Levels Are Significantly Decreased After Rifaximin Therapy in Patients With Diarrhea-Predominant Irritable Bowel Syndrome Whose Inflammatory State May Be Linked to Anti-Vinculin Antibodies (2021) (0)
- Sa1905 IN-VIVO SAFETY OF INTERNALLY APPLIED ULTRAVIOLET-A LIGHT THERAPY: A NOVEL APPROACH FOR ANTI-MICROBIAL/ANTI-INFLAMMATORY TREATMENT (2020) (0)
- Defining Normal Bowel Function Relative to GI Disease: A Systematic Review of the Literature: 1355 (2010) (0)
- 749 - Eradication of Breath Methane Using Antibiotics Results in Changes in Short Chain Fatty Acid Levels in Prediabetic Subjects with Obesity (2018) (0)
- Characterization of Abdominal Pain Response in Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Rifaximin (2017) (0)
- Discontinued products, uncertain data, changing options: Selecting effective and reliable treatment for IBS (2008) (0)
- S541 Symptomatic Response to Antibiotics in Patients With Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis (2022) (0)
- Original contributionIdentification of a prodromal period in Crohn’s disease but not ulcerative colitis (2000) (0)
- Su2119 Introduction of Enteric Methanogens Reduces Intestinal Transit and Alters Oral Glucose Tolerance (2013) (0)
- IRRITABLE BOWEL SYNDROME : ROLE OF GUT BACTERIA AND BACTERIAL TOXINS (2013) (0)
- S0462 The Vital Gut Microbe: The Effect of Methane on the Host's Vital Sign (2020) (0)
- Validation of a Simple Tool (Constipation Minus Diarrhea) for Evaluating Constipation Symptom Outcomes in IBS: 1326 (2009) (0)
- Increased Risk of IBD Among Military Personnel with IBS: 1251 (2010) (0)
- A Combination of Rifaximin and Neomycin Is Most Effective in Treating Patients with Methane on Lactulose Breath Test: 1192 (2008) (0)
- The Response of the Rodent Gut Microbiome to Broad-Spectrum Antibiotics Is Different in Males and Females (2022) (0)
- W1827 Campylobacter Jejuni Clearance Time is Accelerated in Rats That Were Previously Infected at an Early Age (2010) (0)
- W1837 Acute Infection With Campylobacter Jejuni Shows Preferential Colonization in the Distal Small Intestine in Rats (2010) (0)
- Introduction to High-Resolution Manometry and Impedance (2019) (0)
- Sa615 TRANSPLANTATION OF FUSOBACTERIUM VARIUM IN VIVO RESULTS IN AN INCREASE OF PRO-INFLAMMATORY CYTOKINES AND STOOL WET WEIGHT (2021) (0)
- S1313 The First Advanced Network Analysis of the Small Bowel Microbiome in Small Intestinal Bacterial Overgrowth (SIBO) Reveals That Escherichia and Klebsiella Are Disruptive to Network Integrity: Data From the REIMAGINE Study (2020) (0)
- Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study (2023) (0)
- Evidence-based management of irritable bowel syndrome with diarrhea. (2018) (0)
- 257 Assessment of Anti-Vinculin and Anti-CdtB Antibodies in IBS Subtypes (2016) (0)
- 444 – Rifaximin for Improving Abdominal Pain and Bloating Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) Using Modified Definitions of Pain Response (2019) (0)
- 847 Evaluation of Antibodies to Cytolethal Distending Toxin B (CdtB) and Vinculin in Celiac Disease (2015) (0)
- Su1986 - The Non-Absorbable Antibiotic Rifaximin Exhibits Weight Neutrality in the Host (2018) (0)
- Small intestinal bacterial overgrowth is significantly more prevalent in IBS compared to controls (2001) (0)
- Tu2031 The Effect of Rifaximin on Gut Flora in Normal Outbred Rats (2013) (0)
- M1808 Making IBS a “Diagnosis of Inclusion”: Development of a New Diagnostic Criteria for IBS (2008) (0)
- Su381 AN ELEVATION IN METHANE IS ASSOCIATED WITH AN ANTI-INFLAMMATORY CYTOKINE PROFILE SIMILAR TO GLUCOCORTICOIDS (2021) (0)
- Tu1931 LACTOBACILLUS-CONTAINING PROBIOTICS ARE ASSOCIATED WITH CHANGES IN THE SMALL INTESTINAL MICROBIOME BUT NOT WITH SERUM INFLAMMATORY MARKERS: RESULTS FROM THE REIMAGINE STUDY (2020) (0)
- Response to ‘Ultrasound anal sphincter defects and 3D anal pressure defects’ (2017) (0)
- Smoking has disruptive effects on the small bowel luminal microbiome (2022) (0)
- Understanding Harm in the Pharmacotherapy of Irritable Bowel Syndrome with Diarrhea: 1303 (2011) (0)
- Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome (2021) (0)
- Autoimmunity and Irritable Bowel Syndrome: New Pathophysiology (2016) (0)
- Bacteria and the Role of Antibiotics in Irritable Bowel Syndrome (2007) (0)
- Dr. Jeffrey L. Conklin memoriam. (2022) (0)
- ADVANCES IN DIGESTIVE DISORDERS Inside this issue : Evaluating Harm in Medications for IBS (2014) (0)
- Increased Risk for IGE Among Those with IBS: 1338 (2010) (0)
- Reviewer Recognition 2006 (2006) (0)
- Su539 MODERATE TO HEAVY ALCOHOL CONSUMPTION HAS A SIGNIFICANT IMPACT ON THE SMALL INTESTINAL MICROBIOME: NOVEL RESULTS FROM THE REIMAGINE STUDY (2021) (0)
- Abdominal Bloating and Visible Distension (2010) (0)
- Sa1925 THERE ARE MAJOR DIFFERENCES BETWEEN LUMINAL AND MUCOSAL BACTERIAL COMPOSITION IN THE SMALL BOWEL OF HUMANS (2020) (0)
- Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study (2019) (0)
- Treatment of IBS with Nonabsorbable Antibiotics (2007) (0)
- Fourteenth Annual Scientific Meeting (2005) (0)
- History of Tonsillectomy is Associated With Irritable Bowel Syndrome (2011) (0)
- SYN-010 Modified-Release Lovastatin Does Not Significantly Alter Lipid Parameters at Doses that Reduce Methane and Alleviate Symptoms in Patients Suffering Irritable Bowel Syndrome with Constipation (IBS-C): 562 (2016) (0)
- Mo1870 Measuring Anti-Vinculin and Anti-CdtB Antibodies in Two Animal Models of Post-Infectious IBS (2015) (0)
- Assessing the Efficacy of Rifaximin in Diarrhea-Predominant Irritable Syndrome (IBS-D): A Post hoc Analysis of 2 Phase 3, Randomized, Placebo-Controlled Trials: 482 (2017) (0)
- Tu1870 – Endobarrier® Implantation is Associated with Marked Increases in Systemic Inflammatory Cytokines and a Shift Towards a Pro Inflammatory Small Intestinal Microbial Flora (2019) (0)
- M1318 Breath Testing Appears to Discriminate IBS From Healthy Controls: A Systematic Review and Meta-Analysis (2010) (0)
- Tu1455 Antibodies to Cytolethal Distending Toxin of Campylobacter Jejuni Bind to Enteric Neuronal Elements: Further Evidence for Molecular Mimicry (2012) (0)
- “Pre-Cebo”: An Underrecognized Issue in the Interpretation of Adequate Relief During Irritable Bowel Syndrome Drug Trials (2011) (0)
- The Effect of Rifaximin on Staphylococcus Species in the Stool: 549 (2012) (0)
- Novel Approach to C . Diffi cile Infectious Colitis (2009) (0)
- Tu1899 – Microbial Fecalization of the Small Intestine After Long-Term Endobarrier® Implantation (2019) (0)
- Severity of Irritable Bowel Syndrome-Related Symptoms Predicts Clinical Response to the Nonsystemic Antibiotic Rifaximin: 1186 (2008) (0)
- Long Ago and Far Away (2019) (0)
- Diagnosis of constipation by analyzing the concentration of methane (2003) (0)
- Faculty Opinions recommendation of The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis. (2017) (0)
- Tu2056 Antibodies to Cytolethal Distending Toxin B and Auto-Antibodies to Human Vinculin Are Elevated in IBS Subjects (2013) (0)
- 750 - Carbohydrate Metabolic Pathways in Resident Intestinal Bacteria are Upregulated During Chronic Colitis and Exacerbate Intestinal Inflammation (2018) (0)
- Su2059 Vinculin Expression Is Reduced in an Animal Model of Post-Infectious IBS (2013) (0)
- Ultraviolet-A light increases mitochondrial anti-viral signaling protein in confluent human tracheal cells via cell-cell signaling (2021) (0)
- Proton Pump Inhibitors Do Not Affect the Lactulose Hydrogen Breath Test in IBS Subjects: 1325 (2009) (0)
- High-Resolution Manometry Anorectal Manometry: A Comparison with Standard Manometry (2006) (0)
- Evaluation of Rifaximin Efficacy in Non C-IBS Patients by Baseline Disease Severity: Subanalysis of the TARGET 1 and TARGET 2 Studies: 1323 (2011) (0)
- Sa1919 – Intestinal Microbiome Changes After an Antibiotic Regimen are Gender Specific (2019) (0)
- Tu1377: TESTING FOR SMALL INTESTINAL BACTERIAL OVERGROWTH PROVIDES A PRECISION MEDICINE APPROACH TO THE TREATMENT OF IRRITABLE BOWEL SYNDROME: A SYSTEMIC REVIEW AND META-ANALYSIS (2022) (0)
- M1811 Factor Analysis Demonstrates a Symptom Cluster Related to Methane Production in Irritable Bowel Syndrome (IBS) (2008) (0)
- Rifaximin Treatment Consistently Demonstrated Relief Across Daily Symptoms in Patients with Non-Constipation Irritable Bowel Syndrome: Results from 2 Phase 3 Trials (TARGET 1 and TARGET 2): 1312 (2010) (0)
- Methods for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease (2015) (0)
- 458 - Lack of Development of Opportunistic Infections, Including Candidiasis, in Patients with Diarrhea-Predominant Irritable Bowel Syndrome Receiving Repeat Treatment with Rifaximin (2018) (0)
- T1793 Both Campylobacter Jejuni and CDT-C. Jejuni Acutely Reduce the Number of Deep Muscular Plexus Interstitial Cells of Cajal (2009) (0)
- S1580 History of Tonsillectomy Is Seen to Have a Minimal Impact on the Small Intestinal Microbiome (2022) (0)
- PGI22 ESTIMATING DIAGNOSTIC COSTS ASSOCIATED WITH A SECOND-GENERATION BLOOD TEST FOR ANTI-VINCULIN AND ANTI-CYTOLETHAL DISTENDING TOXIN B (CDTB) BIOMARKERS IN COMPARISON TO THE STANDARD EXCLUSIONARY APPROACH FOR IRRITABLE BOWEL SYNDROME WITH A DIARRHEAL COMPONENT (IBS-D/M) (2020) (0)
- Lack of infant breast feeding is associated with small intestinal bacterial overgrowth in adults (2000) (0)
- Obesity and Intestinal Bacteria (0)
- 1041 Efficacy of Rifaximin for IBS Without Constipation in Men and Women (2012) (0)
- Sa1380 Recorded Lower Esophageal Pressures as a Function of Esleevetm Placement and Location of Gastric Pressure Measurement in Patients With Hiatal Hernia (2012) (0)
- 991 High-Resolution Esophageal Manometry Identifies Important Esophageal Motor Dysfunction in Lung Transplant Candidates (2009) (0)
- Diagnosis of Pellagra Should Be Considered in Patients Suspicious for Crohnʼs: 924 (2012) (0)
- Dietary Fat Content Influences the Natural Colonization of Sprague-Dawley Rats With Methanobrevibacter Smithii (2011) (0)
- Antibodies to Campylobacter Jejuni Cytolethal Distending Toxin Subunit B (CDT-B) Bind Enteric Neural Elements in Uninfected Mice Suggesting Molecular Mimicry (2011) (0)
- Su2052 Duodenal Aeromonas SPP Are Increased in Number in a Rat Model of Post-Infectious IBS: Translation of Data From Deep Sequencing of the Microbiome in Humans With IBS (2013) (0)
- Su1211 THE FIRST STUDY TO DETERMINE THE NORMAL RANGE OF EXHALED HYDROGEN SULFIDE (H2S) USING A NOVEL 4-GAS BREATH TEST DEVICE IN HEALTHY SUBJECTS (2020) (0)
- New Onset Gastroesophageal Reflux Disease After Acute Gastroenteritis: A Case of Post-Infectious GERD?: 1000 (2009) (0)
- Sa1680 – Second Generation Anti-Cdtb and Anti-Vinculin Testing Produces Greater Diagnostic Accuracy for Ibs-D Compared to Ibd (2019) (0)
- 717 A Reduced Density of Interstitial Cells of Cajal Predict Small Intestinal Bacterial Overgrowth in a Rat Model of Post-Infectious IBS Secondary to Campylobacter Jejuni (2008) (0)
- Efficacy of Rifaximin on Bowel Movement Urgency in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Pooled Analysis of 3 Phase 3 Trials: 556 (2016) (0)
- W1068 Esophageal Motor Dysfunction and Gastroesophageal Reflux are Prevalent in Patients Awaiting Lung Transplantation (2010) (0)
- W1644 Histological Changes of the Small Intestine Are Seen in the Acute Phase of Infection with Campylobacter Jejuni in a New Rat Model of Post-Infectious IBS (2009) (0)
- Rifaximin for Improving Abdominal Pain and Bloating Symptoms in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) Using Modified Definitions of Pain Response (2018) (0)
- Su2020 Autoimmunity to Vinculin in Humans May Be Important in the Pathophysiology of IBS (2014) (0)
- Tu1750 Gastrointestinal (GI) Symptoms Associated With Excessive Intestinal Methane Production in the Pediatric Population: A Large Database Analysis (2016) (0)
- Fr243 THE FIRST SYSTEMS BIOLOGY APPROACH TO THE MICROBIOME OF SIBO BY HIGH-LEVEL CO-OCCURRENCE COMMUNITY NETWORK ANALYSES IDENTIFIES TWO DISTINCT PROTEOBACTERIA-RELATED CLUSTERS (2021) (0)
- Su1213 GENDER DETERMINES RESPONSE AND RECOVERY OF THE RODENT COLONIC MICROBIOME TO BROAD SPECTRUM ANTIBIOTICS (2020) (0)
- Su1793 Breath Methane and Hydrogen Composition in Inflammatory Bowel Disease (IBD) Is Strikingly Different From Non-IBD Patients and Is Associated With IBD-Associated Genes: A Large-Scale Database Linkage Analysis (2016) (0)
- Response to Drs. Jones et al. (2001) (0)
- Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis: 767 (2017) (0)
- Comparing the rates of methane production in patients with and without appendectomy: results from a large-scale cohort (2020) (0)
- ODP630 Antibiotics Transiently Reduce Circulating Cortisol and Inflammatory Biomarker Levels in Healthy Sprague Dawley Rats (2022) (0)
- Tu1642 - The Immune Response is Modulated in Diarrhea-Predominant IBS Patients via the Inhibition of Mononuclear Leukocytes and Potentially Driven by IL-25 (2018) (0)
- Scintigrapidc features of retrograde dominant constipation (2000) (0)
- 618 THE SMALL INTESTINAL MICROBIOME VARIES WITH AGE: RESULTS FROM THE REIMAGINE STUDY (2020) (0)
- Cost-Minimization For A Novel Ibs Diagnostic Blood Panel Versus Standard Exclusionary Diagnostic Testing For Diarrhea Predominant Irritable Bowel Syndrome: A United States Perspective. (2015) (0)
- Potential For Cost Savings Associated With A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): Italian Perspective. (2015) (0)
- Tu1929 - Improvements in Metabolic Parameters in Pre-Diabetic Subjects with Obesity Following Methane Eradication is Associated with Reduction in Methanogens and Changes in Gut Microbial Populations (2018) (0)
- Response to Drs. Mishkin (2001) (0)
- Sa1372 Can 3D High Resolution Anorectal Manometry Detect Anal Sphincter Defects in Patients With Fecal Incontinence (2015) (0)
- Gender of Gastroenterologist and Years in Practice are Important in Drug Selection for D-IBS: 1756 (2012) (0)
- Repeat Exposure to C. Jejuni Increases the Development of SIBO in a Rat Model of Post-Infectious IBS (2011) (0)
- 131 NORMAL WEIGHT TYPE 2 DIABETES IS ASSOCIATED WITH CHANGES IN THE SMALL BOWEL MICROBIOME THAT APPEAR LINKED TO INCRETIN LEVELS AND GLYCEMIC CONTROL: RESULTS FROM THE REIMAGINE STUDY (2020) (0)
- Tu1914 THE SMALL INTESTINAL MICROBIOME IN OBESITY (WITHOUT DIABETES) HAS MARKED CHANGES WITH ELEVATED LACTOBACILLUS AND A LESS CONNECTED MICROBIAL NETWORK (2020) (0)
- Esophageal Manometry (2019) (0)
- Mo1566 ANTI-VINCULIN AND ANTI-CYTOLETHAL DISTENDING TOXIN B (CDTB) ANTIBODIES ARE LINKED DIRECTLY TO CHANGES IN THE MICROBIOME AND CYTOKINE EXPRESSION AS PART OF THE PATHOPHYSIOLOGY OF POST-INFECTIOUS IBS (2020) (0)
- Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Treated With Rifaximin: 444 (2017) (0)
- Su1940 Methanobrevibacter Smithii is Highly Prominent in the Small Bowel of Rats (2012) (0)
- Tu1518 - Pattern of Hydrogen and Methane Production by Gut Microbiome in Non-Alcoholic Disease (NAFLD): A Large-Scale Matched Case-Control Study (2018) (0)
- Rise in Hydrogen Production During Lactulose Breath Test Does Not Represent Oro-Cecal Transit Due to Lag in Peak Fermentation: 1760 (2012) (0)
- 1149 – Microbial Sequencing of the Appendiceal Microbiome Reveals Elevated Levels of C. Jejuni in Acute Appendicitis (2019) (0)
- Su2039 Staphylococcal Resistance Is Not Seen in an Animal Model of Post-Infectious IBS After Treatment With Rifaximin (2013) (0)
- Sustained Response and Predictors of Sustained Response in Patients who Respond to Multiple Courses of Rifaximin for Diarrhea-Predominant Irritable Bowel Syndrome (2017) (0)
- Analysis of Potential Predictors of Symptom Recurrence in Patients Treated with Rifaximin for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): 2016 ACG Presidential Poster Award: 554 (2016) (0)
- Irritable Bowel Syndrome Is Not Associated with an Increased Risk of Polyps and Colorectal Cancer: A Systematic Review and Meta-Analysis. (2023) (0)
- Su1190 - Characterization of Long-Term Rifaximin Responders from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Repeat Treatment Trial for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (2018) (0)
- Tu1651 - Evaluation of the Role of Sample Size in Determining the True Efficacy of Drugs in IBS: A Meta-Epidemiological Analysis of Randomized Controlled Trials (RCTS) (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mark Pimentel?
Mark Pimentel is affiliated with the following schools:
